SCHEDULE 13G/AFiled Feb 12, 7:00 PM ET

Revance Therapeutics, Inc. SCHEDULE 13G/A

Palo Alto Investors LP

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.